IREN
IREN Limited
There isn't enough reported data to score IREN yet.
SPLS
PIMCO US Stocks PLUS Active Bond Exchange Traded Fund
There isn't enough reported data to score SPLS yet.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
SPLS Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| N/A | |
| N/A |
SPLS's profitability is currently healthy. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like SPLS.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
SPLS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 84x | $54.42 | -0.5% |
| Current | 84x | $54.70 | — |
| Fair | 85x | $55.09 | +0.7% |
| Expensive | 85x | $55.47 | +1.4% |
Historical ranges are pointers, not guarantees.
SPLS's PE is 84x, but its earnings don't support one, so it isn't a reliable read right now.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
SPLS Forward outlook
There aren't enough analyst estimates for SPLS to show an outlook.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
SPLS has the stronger earnings trend. Trailing diluted EPS is down 347% for IREN versus SPLS down 21%.
SPLS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2014 | $0.82 | +$1.11 |
| Q2 2014 | $0.85 | +$1.12 |
| Q1 2014 | $0.96 | +$1.22 |
| Q4 2013 | $0.75 | +2400% |
| Q3 2013 | -$0.29 | -122% |
| Q2 2013 | -$0.27 | -119% |
| Q1 2013 | -$0.26 | -118% |
| Q4 2012 | $0.03 | -98% |
SPLS's earnings per share have fallen from their peak: $0.65 over the past year, against $1.41 in early 2012.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN has the stronger quarterly revenue trend. Revenue is down 5.1% for IREN versus down 18% for SPLS.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
SPLS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2017 | $3.9B | -18% |
| Q2 2017 | $4.1B | -19% |
| Q1 2017 | $3B | -42% |
| Q3 2016 | $4.8B | -3.7% |
| Q2 2016 | $5.1B | -3.1% |
| Q1 2016 | $5.3B | -6.9% |
| Q3 2015 | $4.9B | -5.4% |
| Q2 2015 | $5.3B | -6.9% |
SPLS's revenue has slid since its 2011 peak: $3.9B last quarter, down 18% from the same quarter a year ago.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
SPLS has the stronger cash trend. Its trailing FCF is up 31% versus its history, compared with IREN at down 479%.
SPLS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2017 | -$31M | +$314M |
| Q2 2017 | $221M | -4.7% |
| Q1 2017 | $207M | +90% |
| Q3 2016 | -$345M | -$267M |
| Q2 2016 | $232M | -3.3% |
| Q1 2016 | $109M | +$134M |
| Q3 2015 | -$78M | +$40M |
| Q2 2015 | $240M | -23% |
SPLS's free cash flow was $982M over the past year, against −$82M the year before. Free cash flow isn't a meaningful measure for financial services companies like SPLS.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
SPLS Net Leverage
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
SPLS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 66.6 | Neutral |
| Stochastic | 31.7 | Neutral |
SPLS's weekly RSI is 67 (neutral) and its Stochastic is 32 (neutral).
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
SPLS PE vs Financial Services Sector
| Metric | SPLS | Sector median | Relative |
|---|---|---|---|
| PE | 84x | 13x | 543% above |
SPLS is trading at 84x earnings, a 543% premium to the Financial Services sector's median of 13x, though its earnings don't support one.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
SPLS has stronger trend alignment. IREN is above 1 of 5 weekly averages versus SPLS above 2 of 4.
SPLS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $54.9 | 0.4% below |
| 20 week MA | $55.0 | 0.5% below |
| 50 week MA | $39.0 | 40% above |
| 100 week MA | $24.0 | 128% above |
SPLS has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 128% above its 100-week average.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.
SPLS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2016 | $9.62 | $9.22 | -4.2% |
| 2017 | $9.22 | $10.3 | +11% |
| 2026 YTD | $10.3 | $54.7 | +434% |
SPLS has the edge over IREN on returns for 2026, with the stronger performance.